Norbert Galldiks/fz-juelich.de
Dec 3, 2024, 16:22
Norbert Galldiks: Identifying Metabolic Responders to Vorasidenib in IDH-Mutant Gliomas
Norbert Galldiks, Professor for Neurology at University Hospital Cologne, shared an article on X:
“Happy to share our latest work.
Our initial results suggest the potential of amino acid PET using FET for identifying metabolic responders to vorasidenib in IDH-mutant gliomas.”
Evaluation of early metabolic changes following vorasidenib using FET PET in patients with IDH-mutant gliomas.
Authors: Norbert Galldiks, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 2, 2025, 00:00
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32